STEEP1 and breast cancer: Notably, higher CXorf56 transcript levels were observed in the TNBC tissues (immunohistochemistry subtype) or basal-like breast cancer tissues (PAM50 subtype) than in other breast cancer tissues (Fig. 1F, G).